login
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 
SEATTLE II results show no intracranial haemorrhage or no death among pulmonary embolism patients
Tue Aug 25, 2015
The study concluded that treatment with ultrasound-facilitated catheter-directed low-dose thrombolysis for acute pulmonary embolism improves right heart function, reduces blood clot size, and decreases pulmonary hypertension in patients with intermediate to high risk pulmonary embolism. SEATTLE II results show no intracranial haemorrhage or no death among pulmonary embolism patients

TriVascular enrols first patient in the LUCY study
Tue Aug 25, 2015
The first of its kind study aims to evaluate endovascular aortic repair (EVAR) in the under-served female population. TriVascular enrols first patient in the LUCY study

Updated screening policies could detect more abdominal aortic aneurysms
Thu Aug 20, 2015
Updating national screening policies could help detect a deadly form of aneurysm in older men; saving lives and resources, according to research presented in the Journal of the American Heart Association. Updated screening policies could detect more abdominal aortic aneurysms

Interview with Ian Franklin at CX 2015: New venous technologies

Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the hands-on workshop.

Janet Powell
Thu Jul 23, 2015
In this interview, Janet Powell explains why the cause and management of abdominal aortic aneurysms are her major research interests and speaks about her early career, her mentors, the IMPROVE randomised controlled trial, and also her interests outside medicine. Janet Powell
Jean-Baptiste Ricco
Tue Mar 3, 2015
Jean-Baptiste Ricco, Poitiers, France, is the immediate past-president of ESVS and for over 15 years held an editor’s position with EJVES. In this interview, Ricco tells Vascular News about his mentors in vascular surgery, achievements in the ESVS and journal, and his volunteering experience ... Jean-Baptiste Ricco
Gunnar Tepe
Tue Dec 9, 2014
Gunnar Tepe was involved in the development of the first drug-coated balloons for the treatment of peripheral arterial disease. Tepe, who is also principal investigator of the IN.PACT SFA trial, tells Vascular News about his career, drug-eluting balloons research and interests outside medicine ... Gunnar Tepe
Imaging atherosclerosis

Imaging atherosclerosis

Researchers from the UK have shown how a radioactive agent developed in the 60s to detect bone cancer can be repurposed to highlight the build-up of unstable calcium deposits in arteries.
Vascular access procedure selection for the elderly patient on haemodialysis David Cull, Greenville, USA, writes that vascular access placement in the elderly needs to take into account patients’ physiological age in an effort to predict survival. Vascular access procedure selection for the elderly patient on haemodialysis

Robotic vena cava surgery for tumour and filter removal A robotic surgical system provides the advantages of better visualisation with magnification, 3D vision, tremor filtration, and seven degrees of freedom in addition to a more ergonomic and ... Robotic vena cava surgery for tumour and filter removal











Ranger drug-coated balloon

The Ranger drug-coated balloon (Boston Scientific) is indicated for percutaneous transluminal angioplasty in the peripheral vasculature. It has been designed to provide consistent and predictable drug delivery through efficient drug transfer, and a strong coating integrity.

The medicines cost-effectiveness body for England and Wales has recommended a new treatment to help patients suffering from blood clots in the legs and lungs. NICE recommends once-daily Lixiana (edoxaban) to treat and prevent adult recurrent deep vein thrombosis and pulmonary embolism

Daiichi Sankyo’s European ETNA registries are part of the global ETNA initiative which is comprised of regional patient registries designed to reflect regional needs and local clinical practice. Real world ETNA registries of new once-daily edoxaban commence in Europe

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions